Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Hypoxia-inducible factor-1 can reverse the Adriamycin resistance of breast cancer adjuvant chemotherapy by upregulating transferrin receptor and activating ferroptosis
Some studies report mild side effects or adverse reactions
A higher-dose option is also available (10mg BPC-157, 10mg TB-500, 50mg GHK-Cu) for studies requiring increased peptide concentrations
Pause-and-resume short 3-5 day breaks when site reactions persist or flushing becomes socially intrusive
US$ 29.77
US$ 22.40
US$ 25.41
US$ 25.20
US$ 26.83
US$ 25.65
US$ 27.02
US$ 22.03
US$ 20.14
US$ 29.42
